Detalhe da pesquisa
1.
Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lung.
Eur J Immunol
; 41(11): 3312-22, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21818755